Literature DB >> 9575496

Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases.

T Cawston1.   

Abstract

The matrix metalloproteinases (MMPs) are a unique family of metalloenzymes, which, once activated, can destroy all the components of cartilage. MMPs are found in resorbing cartilage, bone, rheumatoid and osteoarthritic synovial fluid, and adjacent soft tissues. The active enzymes are all inhibited by tissue inhibitors of metalloproteinases (TIMPs). The relative amounts of active MMPs and TIMPs are important in determining whether cartilage is broken down in joint diseases. Conventional treatments for arthritis do little to affect the underlying joint destruction, but new drugs are now available that can specifically block active MMPs. These potent inhibitors prevent the destruction of cartilage both in vitro and in animal models of arthritis. Future trials in patients will test their effectiveness in the prevention of cartilage destruction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575496     DOI: 10.1016/s1357-4310(97)01192-1

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  30 in total

1.  The fluence effects of low-level laser therapy on inflammation, fibroblast-like synoviocytes, and synovial apoptosis in rats with adjuvant-induced arthritis.

Authors:  Yueh-Ling Hsieh; Yu-Jung Cheng; Fang-Chuen Huang; Chen-Chia Yang
Journal:  Photomed Laser Surg       Date:  2014-12       Impact factor: 2.796

Review 2.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

3.  Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis.

Authors:  Mandana Mahmoodi; Solmaz Sahebjam; David Smookler; Rama Khokha; John S Mort
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

4.  Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis.

Authors:  P L van Lent; K Nabbe; A B Blom; A E Holthuysen; A Sloetjes; L B van de Putte; S Verbeek; W B van den Berg
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.

Authors:  Jinan Li; Annelii Ny; Göran Leonardsson; Kutty Selva Nandakumar; Rikard Holmdahl; Tor Ny
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR.

Authors:  El-Sayed Akool; Hartmut Kleinert; Farid M A Hamada; Mohamed H Abdelwahab; Ulrich Förstermann; Josef Pfeilschifter; Wolfgang Eberhardt
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro.

Authors:  R L Van Bezooijen; L Van Der Wee-Pals; S E Papapoulos; C W G M Löwik
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

9.  The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.

Authors:  Peter van Lent; Karin C Nabbe; Peter Boross; Arjen B Blom; Johannes Roth; Astrid Holthuysen; Annet Sloetjes; Sjef Verbeek; Wim van den Berg
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Inhibitory effect of cyclo-oxygenase-2 inhibitor on the production of matrix metalloproteinases in rheumatoid fibroblast-like synoviocytes.

Authors:  H S Cha; K S Ahn; C H Jeon; J Kim; E M Koh
Journal:  Rheumatol Int       Date:  2003-07-26       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.